MicroRNAs - Novel therapeutic targets of eicosanoid signalling

10Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MicroRNAs (miRNAs) have emerged as important regulators in human physiological and pathological processes. We summarize the current knowledge about the role of miRNA involved in the control of inflammatory responses with a special focus on eicosanoid signalling. Cyclooxygenase 2 - the key enzyme of the prostanoid pathway - is regulated by different miRNAs such as miRNA-101, miR199a, miR26b and miR-146a. In contrast to this, the understanding of miRNA regulation on enzymes of the leukotriene biosynthesis is just at the beginning. The knowledge of miRNAs regulating enzymes of the eicosanoid pathway offers a new way for the development of new therapeutic concepts for the treatment of inflammatory diseases. © 2013 Nordic Pharmacological Society.

Cite

CITATION STYLE

APA

Ochs, M. J., Steinhilber, D., & Suess, B. (2014, January). MicroRNAs - Novel therapeutic targets of eicosanoid signalling. Basic and Clinical Pharmacology and Toxicology. https://doi.org/10.1111/bcpt.12116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free